ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,014Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 692

$1M Total Retail Price of All Prescriptions

Rank: 86 out of 692

555 Patients Receiving at Least One Drug in Part D
74% Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Louisiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

3% of this provider’s 555 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

32% of this provider’s 555 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 929 553 166 S3 1 3
LEVOTHYROXINE SODIUM 669 466 102 2 2
GABAPENTIN 550 348 110 3 12
FUROSEMIDE 540 376 109 4 7
LISINOPRIL 534 321 90 5 4
SIMVASTATIN 530 347 94 6 5
OMEPRAZOLE 483 365 86 7 8
POTASSIUM CHLORIDE 453 303 87 8 14
CLOPIDOGREL 446 321 77 9 17
AMLODIPINE BESYLATE 414 337 75 10 1
METOPROLOL TARTRATE 401 280 77 11 16
ALPRAZOLAM 397 254 71 B 12 15
CIPROFLOXACIN HCL 392 271 229 13 64
TRAMADOL HCL 388 292 89 14 20
ALLOPURINOL 371 305 56 15 36
METFORMIN HCL 362 193 74 16 9
NEXIUM 355 204 56 17 18
PANTOPRAZOLE SODIUM 301 214 60 18 23
HYDROCHLOROTHIAZIDE 297 228 59 19 11
METOPROLOL SUCCINATE 287 240 54 20 13
ATORVASTATIN CALCIUM 247 144 45 21 6
ZOLPIDEM TARTRATE 234 153 50 22 25
PRAVASTATIN SODIUM 229 178 45 23 10
ISOSORBIDE MONONITRATE ER 222 145 34 24 66
LOSARTAN POTASSIUM 191 110 31 25 19
GLIPIZIDE 190 151 30 26 62
MELOXICAM 181 135 45 27 24
SERTRALINE HCL 177 98 33 28 31
CITALOPRAM HBR 170 99 27 29 26
FLUTICASONE PROPIONATE 165 110 77 30 39
ATENOLOL 157 136 25 31 22
LEVOCETIRIZINE DIHYDROCHLORIDE 146 119 34 32 135
KLOR-CON M20 137 80 25 33 72
WARFARIN SODIUM 136 97 26 34 28
CRESTOR 123 118* 17 35 27
JANUVIA 119 108 13 36 59
TRAZODONE HCL 117 71 22 37 44
AMITRIPTYLINE HCL 117 101 20 R 37 58
DONEPEZIL HCL 114 114 18 39 32
MIRTAZAPINE 112 96 23 40 76
AMLODIPINE BESYLATE-BENAZEPRIL 111 51 17 41 48
TIZANIDINE HCL 111 59 26 41 111
ALENDRONATE SODIUM 110 82 18 43 40
TAMSULOSIN HCL 105 105 23 44 35
SYNTHROID 104 90 19 45 42
METHYLPREDNISOLONE 103 64 75 46 92
PAROXETINE HCL 99 75 19 47 84
LANTUS SOLOSTAR 96 64 23 48 78
CLONAZEPAM 96 63 14 B 48 46
NATEGLINIDE 92 76 20 50 218
CLONIDINE HCL 90 51 24 51 37
MUPIROCIN* 90 64 53 51 145
CARISOPRODOL 89 15 16 R 53 91
SUCRALFATE 88 73 36 54 150
CARVEDILOL 87 59 20 55 21
FLUCONAZOLE 87 49 49 55 147
BD ULTRA-FINE PEN NEEDLE 85 60 27 57 118
METFORMIN HCL ER 83 61 27 58 54
MECLIZINE HCL 82 63 32 59 101
SULFAMETHOXAZOLE-TRIMETHOPRIM 82 38 56 59 94
PROAIR HFA 81 41 29 61 60
OXYBUTYNIN CHLORIDE 81 70 19 61 129
ESCITALOPRAM OXALATE 77 43 11 63 33
TRADJENTA 76 <11 <11 64 194
ETODOLAC 76 55 19 64 230
PREDNISONE 76 54 20 64 53
LANTUS 76 42 16 64 61
LORAZEPAM 75 61 19 B 68 43
RAMIPRIL 75 58 14 68 77
TRIAMTERENE-HCTZ 73 <11 <11 70 56
AMOX TR-POTASSIUM CLAVULANATE 71 47 52 71 116
ONGLYZA 70 45 21 72 149
SPIRIVA 70 46 23 72 74
ENALAPRIL MALEATE 69 69 12 74 71
MONTELUKAST SODIUM 69 <11 <11 74 49
RANITIDINE HCL 68 55 18 76 65
DIOVAN 68 41 12 76 34
AZELASTINE HCL 68 51 29 76 239
CLOTRIMAZOLE-BETAMETHASONE 67 46 38 79 207
QUETIAPINE FUMARATE 66 33 12 A 80 50
LYRICA 65 <11 <11 81 70
CYMBALTA 65 <11 <11 81 41
GLIPIZIDE ER 64 37 12 83 131
NAMENDA 63 63 12 84 29
ADVAIR DISKUS 62 30 20 85 57
FENTANYL 62 <11 <11 S2 85 171
AZITHROMYCIN 61 43 42 87 51
ESTRADIOL 61 <11 <11 R 87 146
PROMETHAZINE HCL 61 33 22 R 87 89
CEFUROXIME 60 41 49 90 159
TEMAZEPAM 59 23 13 B 91 67
KLOR-CON M10 58 45 15 92 155
KLOR-CON 10 58 40 16 92 174
BUSPIRONE HCL 58 32 11 92 133
BENAZEPRIL HCL 57 52* 14 95 47
ZETIA 57 <11 <11 95 83
CELEBREX 56 <11 <11 97 87
SPIRONOLACTONE 56 37 13 97 82
FAMOTIDINE* 56 <11 <11 97 95
FENOFIBRATE* 56 <11 <11 97 55
PRADAXA 54 <11 <11 101 231
POLYETHYLENE GLYCOL 3350 52 47* 19 102 69
VALSARTAN-HYDROCHLOROTHIAZIDE 52 <11 <11 102 63
PHENYTOIN SODIUM EXTENDED 50 <11 <11 104 127
GLIMEPIRIDE 50 39 12 104 30
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.